VERICEL CORPORATION (VCEL) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $750.80M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-365.00K; Retained Earnings (Accumulated Deficit)USD $-380.39M; Stockholders' Equity Attributable to ParentUSD $370.04M.
- 2026-03-31: Common Stock, Value, IssuedUSD $739.00M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-168.00K; Retained Earnings (Accumulated Deficit)USD $-382.60M; Stockholders' Equity Attributable to ParentUSD $356.23M.
- 2025-12-31: Common Stock, Value, IssuedUSD $730.66M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $275.00K; Retained Earnings (Accumulated Deficit)USD $-376.30M; Stockholders' Equity Attributable to ParentUSD $354.64M.
- 2025-09-30: Common Stock, Value, IssuedUSD $721.14M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $258.00K; Retained Earnings (Accumulated Deficit)USD $-399.54M; Stockholders' Equity Attributable to ParentUSD $321.86M.
VERICEL CORPORATION Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Value USD | Preferred Stock, Value, Outstanding USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $750.80M | $-365.00K | $-380.39M | $370.04M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $739.00M | $-168.00K | $-382.60M | $356.23M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $730.66M | $275.00K | $-376.30M | $354.64M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $721.14M | $258.00K | $-399.54M | $321.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $711.24M | $183.00K | $-404.61M | $306.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $699.41M | $136.00K | $-404.06M | $295.49M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $684.78M | $4.00K | $-392.81M | $291.97M | 12 month · $36.49M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $669.74M | $359.00K | $-412.62M | $257.47M | 3 month · $9.22M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $654.97M | $-273.00K | $-411.72M | $242.98M | 3 month · $9.52M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $641.18M | $-245.00K | $-407.04M | $233.90M | 3 month · $9.83M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $629.23M | $-100.00K | $-403.18M | $225.95M | 12 month · $32.33M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $621.01M | $-463.00K | $-416.17M | $204.38M | 3 month · $7.92M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $612.06M | $-621.00K | $-412.51M | $198.93M | 3 month · $8.76M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $602.10M | $-636.00K | $-407.49M | $193.98M | 3 month · $8.73M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $593.25M | $-978.00K | $-400.00M | $192.27M | 12 month · $37.18M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $584.90M | $-1.15M | $-405.92M | $177.84M | 3 month · $9.10M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $575.01M | $-855.00K | $-399.34M | $174.82M | 3 month · $10.81M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $563.48M | $-613.00K | $-390.38M | $172.49M | 3 month · $9.53M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $553.90M | $-154.00K | $-383.29M | $170.46M | 12 month · $34.32M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $544.62M | $-23.00K | $-387.82M | $156.78M | 3 month · $8.60M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $534.00M | $-23.00K | $-382.89M | $151.09M | 3 month · $10.87M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $519.36M | $-47.00K | $-379.10M | $140.21M | 3 month · $7.02M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $510.06M | $14.00K | $-375.81M | $134.26M | 12 month · $13.84M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $502.59M | $78.00K | $-388.04M | $114.63M | 3 month · $2.67M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $499.10M | $146.00K | $-391.65M | $107.60M | 3 month · $4.38M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $493.77M | $62.00K | $-383.38M | $110.45M | 3 month · $3.77M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $489.75M | $21.00K | $-378.68M | $111.09M | 12 month · $13.18M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $485.14M | $29.00K | $-388.18M | $96.99M | 3 month · $3.29M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $480.05M | $38.00K | $-391.65M | $88.54M | 3 month · $4.18M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $474.81M | $3.00K | $-371.86M | $103.06M | 3 month · $2.63M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $471.18M | $-39.00K | $-369.01M | $102.23M | 12 month · $7.22M | (m) | (m) | 12 month · $4.70M | (m) | (m) | (m) |
| 2018-09-30 | $468.45M | $-18.00K | $-374.26M | $94.47M | 3 month · $1.93M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $463.48M | (m) | $-373.19M | $90.60M | 3 month · $2.46M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $389.07M | (m) | $-368.54M | $20.93M | 3 month · $1.35M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $383.02M | $0.00 | $-360.88M | $22.54M | 12 month · $2.68M | (m) | (m) | 12 month · $311.00K | 12 month · $207.00K | (m) | (m) |
| 2017-09-30 | $377.71M | (m) | $-361.16M | $16.74M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $369.54M | (m) | $-355.76M | $13.97M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $368.68M | (m) | $-353.37M | $15.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $329.72M | $190.00K | $-343.59M | $24.71M | 12 month · $2.50M | $0.00 | (m) | 12 month · $1.65M | 12 month · $190.00K | (m) | 0.00 |
| 2016-09-30 | $310.21M | (m) | $-337.39M | $11.39M | (m) | $3.15M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $309.44M | (m) | $-330.72M | $17.11M | (m) | $3.15M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $308.51M | (m) | $-327.68M | $19.23M | (m) | $3.15M | $38.39M | (m) | (m) | (m) | (m) |
| 2015-12-31 | $307.77M | $0.00 | $-324.02M | $22.13M | 12 month · $2.75M | $3.15M | $38.39M | 12 month · $3.17M | (m) | (m) | 1.25M |
| 2015-09-30 | $307.21M | $-71.00K | (m) | $26.41M | (m) | (m) | $38.39M | (m) | (m) | (m) | (m) |
| 2015-06-30 | $306.62M | $-71.00K | (m) | $30.24M | (m) | (m) | $38.39M | (m) | (m) | (m) | (m) |
| 2015-03-31 | $305.93M | $-71.00K | (m) | $31.70M | (m) | (m) | $38.39M | (m) | (m) | (m) | (m) |
| 2014-12-31 | $305.01M | $-71.00K | (m) | $35.64M | 12 month · $839.00K | $0.00 | $38.39M | 12 month · $3.17M | (m) | (m) | 1.25M |
| 2014-09-30 | $304.78M | $-70.00K | (m) | $37.78M | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 9 month · $0.00 | (m) |
| 2014-06-30 | $262.79M | $5.00K | (m) | $2.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $259.14M | (m) | $-293.76M | $3.77M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $253.27M | (m) | $-287.76M | $3.89M | 12 month · $926.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $251.36M | (m) | $-284.80M | $4.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $245.98M | (m) | $-287.01M | $-41.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $245.55M | (m) | $-282.12M | $-36.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $243.22M | (m) | $-275.31M | $-32.10M | 12 month · $3.61M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $242.77M | (m) | $-267.41M | $-24.64M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $239.45M | (m) | $-260.16M | $-20.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $229.87M | (m) | $-251.59M | $-21.72M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $228.88M | (m) | $-241.85M | $-12.97M | 12 month · $3.74M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | $227.90M | (m) | $-239.06M | $-11.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $226.97M | (m) | $-237.12M | $-10.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $225.10M | (m) | $-222.18M | $2.92M | 6 month · $1.04M 261 month · $10.13M | (m) | (m) | (m) | 261 month · $3.50M | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | $14.78M | 12 month · $710.00K 255 month · $9.09M | (m) | (m) | 255 month · $2.87M | 255 month · $3.50M | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | $16.75M | 243 month · $8.38M | (m) | (m) | 243 month · $2.87M | 243 month · $3.50M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |